Leveraging the technological capabilities we have cultivated over many years as a manufacturer with the top share in the OTC eye care category, we will develop Ophthalmology area as a new business area.
In March 2020, we acquired Japan Eye Drop Research Institute Co., Ltd. (currently Rohto Nitten Co., Ltd.), a manufacturer of prescription ophthalmic drugs, as a subsidiary, securing resources for manufacturing and sales. Currently, we are collaborating with other companies to develop prescription ophthalmic drugs, while also conducting Regenerative medicine research in the ophthalmology field and developing ophthalmic medical devices.